The anticholinergic anti-parkinsonism drug Norakin R is an inhibitor of influenza virus multiplication. By crossing a Norakin-resistant variant of fowl plague virus (FPV) strain Weybridge with the sensitive FPV/Rostock/34 wild-type virus, Norakinresistant recombinants were obtained. Analyses of the gene composition showed that all Norakin-resistant recombinants had inherited their haemagglutinin gene from the Norakin-resistant parent strain. The majority of the recombinants had received all the other gene segments from the sensitive parent strain. Norakin was shown to inhibit red blood cell lysis induced either by purified virions or by the haemagglutinin of a sensitive FPV strain at low pH, but failed to affect the Norakin-resistant FPV variant. No aggregation of autoliposomes containing the haemagglutinin of a sensitive FPV strain or digestion of the HA1 subunit of haemagglutinin by trypsin occurred in the presence of Norakin at acid pH. The data suggest that the haemagglutinin of FPV is the target for the antiviral activity of Norakin, which acts by inhibiting the conformational change in the haemagglutinin at acid pH important for lysis.
INTRODUCTION
The aim of our work was to identify the product(s) of the gene(s) that is a target for the antiviral effect of Norakin R (Presber et al., 1984) and to reveal the stage of influenza virus multiplication which is blocked by this inhibitor.
METHODS
Compound. Norakin (triperiden hydrochloride), an anti-parkinsonism drug (VEB Fahlberg List, Magdeburg, G.D.R.) , is predominantly an anticholinergic drug (Vernier, 1981) . This preparation has been shown previously to inhibit the multiplication of influenza viruses in a number of cell cultures (Presber et al., 1984) . Norakin differs from amantadine and its derivatives in its chemical structure (Presber et al., 1984) .
Viruses and cells. The Norakin-sensitive wild-type fowl plague virus (FPV) strain A/FPV/Rostock/34 (H7N1) and a Norakin-resistant strain A/FPV/Weybridge r (H7N7) were used. Viruses were propagated in 10-day-old chick embryos. All experiments were performed in primary chick embryo fibroblast (CEF) cultures.
Isolation oJNorakin-resistant virus recombinants. CEF cultures were infected simultaneously with partially u.v.-inactivated (titre reduction of 3 log t0 units) Norakin-resistant FPV/Weybridge r and the sensitive wild-type strain FPV/Rostock/34. The multiplicities of infection were 0.1 p.f.u./cell for the resistant (based on titre before u.v. treatment) and 1 p.f.u./cell for the sensitive parent strain. After a 30 min adsorption period at room temperature, unadsorbed virus was removed by washing. Medium 199 was added and incubation continued for 18 h at 36 °C. Virus yields were determined by the plaque method without inhibitor and in the presence of 15 ~tg Norakin/ml. Clones isolated from plaques that developed under Norakin-containing overlay were propagated in CEF cultures in Medium 199 containing Norakin at a concentration of 20 ~tg/ml and checked once more for drug resistance by the plaque method. Several recombinants were obtained by a different procedure. In this, the CEF monolayers were first infected with the partially u.v.-inactivated Norakin-resistant Weybridge strain at a m.o.i, of 0.1 p.f.u./cell based on the titre before the u.v. treatment. Following a 30 min adsorption period at 36 °C, the cultures were superinfected with the sensitive Rostock strain at a mo.i. of 10 -3 to 10 -a p.f.u./cell. After a further 1 h 0000-6789 © 1986 SGM adsorption period, unadsorbed virus was removed by washing and the monolayer covered with an agar overlay containing 15 gg Norakin/ml. Clones were isolated from the plaques formed, and tested for Norakin resistance by the plaque method with or without the inhibitor. All isolated recombinants were subjected to two cycles of plaque purification in the presence of Norakin (15 ~tg/ml).
Genome analysis ofrecombinants. The genomes of the recombinants were analysed by the method developed by Hay et al. (1977a) and described previously in detail (Ghendon et al., 1979) . CEF cultures were infected with recombinant viruses (m.o.i. 100 p.f.u./cell) and incubated in the presence of cycloheximide (100 ~g/ml) for 1 h at 36 °C. Then [3H]uridine (100 ~tCi/ml) was added and incubation continued for another 3.5 h. Total labelled RNA was extracted from the infected cells, and aliquots were hybridized with an excess of purified viral RNA (vRNA) from each of the parent strains. They were then treated with S1 nuclease, precipitated with ethanol and analysed by polyacrylamide gel electrophoresis (PAGE) in 4~ gels or in 7.5 ~ gels containing 6 M-urea. Using this method, we have previously shown that all eight genes of the two FPV strains Weybridge and Rostock can be distinguished (Markushin et al., 1981) .
Red blood celllysis. Ten ~tg of purified virions or 5 gg of autoliposomes (see below) containing haemagglutinin, in 10 lal were put into a test-tube. The volume was adjusted to 200 ktl with MM buffer (0.005 M-Tris-HC1, 0.14 M-NaCI; pH 7.0) and 300 ~tl of an 8% suspension of chicken red blood cells was added. The mixture was incubated for 10 min at 0 °C, then 500 ~tl of citrate buffer was added (0.2 M-sodium citrate, 0.14 M-NaC1; pH 5.2) and incubated for a further 30 min at 37 °C. To study the influence of Norakin on FPV-induced red blood cell lysis, 200 ~tg of Norakin in a volume of 10 gl was added to 10 ~g of the virus or to 5 ~tg of autoliposomes in a volume of 10 gl; the resulting volume was adjusted to 200 ~tl with MM buffer. The mixture was incubated for 10 min at 20 °C, 300 ~tl of an 8~ suspension of chicken red blood cells was added, and the reaction was performed as described above. The extinction value was determined using a Beckman 35 spectrophotometer at 520 nm . Production of purified FPV virions and autoliposomes containing haemagglutinin. Purified FPV virions were obtained by means of a discontinuous sucrose gradient (20 and 60~ sucrose) using the method of Hay et al. (1977b) . To obtain autoliposomes, purified virions were suspended in MM buffer at a protein concentration of 1 to 3 mg/ml and broken up by adding octyl-fl-glucopyranoside to a concentration of 1 to 1.5~. The suspension was centrifuged for 90 min at 150000g at 4 °C (MSE Superspeed 65, 3 x 6.5 rotor). Supernatant (2 to 5 ml) was applied to a column of Sepharose 6B (15 mm × 25 cm) equilibrated with MM buffer; gel filtration was performed using the same buffer at a flow rate of 35 ml/h. The absorbance of the fractions was determined at 280 nm using a Uvicord II spectrophotometer (LKB). Liposomes, containing lipids and FPV haemagglutinin, were seen as a sharp peak in the void volume of the column. The material is described in Results.
Analysis of the influence of Norakin on aggregation of haemagglutinin at acid pH. Fifteen i.tg of FPV haemagglutinin-containing autoliposome preparation in 150 I~1 MM buffer was mixed with 500 p.l water. The samples were incubated for 10 min at 30 °C, 2 vol. citrate buffer (see above) was added, and the mixture was incubated at 37 °C for 10 min. Norakin-free autoliposome mixture, with 2 vol. MM buffer (pH 7.0) added instead of the citrate buffer (pH 5.2), was used as a control. All the samples were applied onto 20 to 50~ sucrose gradients in MM buffer, and centrifuged at 10000 r.p.m, for 17 h at 4 °C (MSE Superspeed 65, 6 x 38 rotor). Purified FPV virions (450S) analysed in the same sucrose gradient were used as a visible marker. A2s0 was determined in the gradient fractions using a Beckman Model 35 spectrophotometer.
Analysis of the influence of Norakin on sensitivity to trypsin at acid pH of the HA1 subunit of the haemagglutinin.
Eighty gl of water containing 400 ~g of Norakin, or water alone, was added to 10 ~tg of liposomes in 200 gl of MM buffer at pH 7.0, and the mixture was incubated for 15 min at 20 °C. Two-hundred and eighty lal of citrate buffer (pH 5.2) was added to this mixture and 280 p.1 of MM buffer (pH 7.0) was added to the control samples. The samples were then incubated for 15 min at 20 °C, and 560 ~1 1.0 M-Tris-HC1 buffer pH 7-3 was added to each sample; to some of the samples was added 10 l-tl water containing 10 ~g trypsin (twice-crystallized; Serva, Heidelberg, F.R.G.). After 90 min of incubation at 20 °C 2.5 vol. acetone was added to each sample, and the mixtures were incubated overnight at -20°C. The pelleted precipitate was solubilized and subjected to electrophoresis in a 25~ polyacrylamide gel. Bands on gels, stained with Coomassie Brilliant Blue G-250, were quantified using a MSD-3 Joyce-Loebl microdensitometer.
RESULTS

Norakin sensitivity of the clones isolated after recombination
Progeny clones and the two parental strains were checked for Norakin sensitivity. Table 1 shows that the initial titre of A/FPV/Rostock/34 was reduced by almost 2 log10 units with 15 I-tg Norakin/ml, whereas FPV/Weybridge r was completely resistant. All seven clones isolated after recombination were as resistant as FPV/Weybridge r. The analysis was performed in 7-5~ polyacrylamide gels in the presence of 6 M-urea as described in Methods. 3H-labelled cRNA of the recombinant was hybridized with unlabelled vRNA of each parent strain. The nuclease Sl-treated hybrids were separated by electrophoresis, cRNAs W, Rs and R4 were derived from FPV strains Weybridge r, Rostock and the recombinant R4, respectively; vRNAs W and Rs were from the parental strains. The numbers indicate 1 to 8 the positions of dsRNA hybrids corresponding to the genes of parent strains Weybridge r (left) and Rostock (right). 
Analysis of the genomes of Norakin-resistant recombinants
In order to identify the gene(s) responsible for N o r a k i n resistance we chose for g e n o m e analysis five Norakin-resistant clones isolated by two different r e c o m b i n a t i o n procedures. Fig.  1 shows the analysis of r e c o m b i n a n t R4 and the two parent strains after u r e a -P A G E .
O n homologous hybridization of c o m p l e m e n t a r y R N A ( c R N A ) to v R N A of the parental strains, followed by nuclease S1 digestion, eight bands of double-stranded R N A were visible, whereas heterologous hybridization and subsequent nuclease S1 digestion did not reveal any bands corresponding to segments of either of the parent strains (Fig. 1) . This supports our previous demonstration of differences in the degree of homology of all genes between the two F P V strains, Weybridge and Rostock (Markushin et al., 1981) . 
* Genome analysis was performed as outlined in Methods and as shown for R4 in Fig. 1 . W, Gene inherited from the Weybridge parent strain; R, gene inherited from the Rostock parent strain.
t RNA segment number.
When cRNA of the recombinant R4 was hybridized with vRNA of A/FPV/Rostock/34 seven bands appeared which corresponded to RNA segments 1, 2, 3, 5, 6, 7 and 8 of A/FPV/Rostock/34. The hybridization of this cRNA with vRNA of A/FPV/Weybridge r resulted in the appearance of one double-stranded RNA corresponding in mobility to segment 4 of A/FPV/Weybridge r. The second major band, located below it, did not correspond in its electrophoretic mobility to the homologous hybrid of segment 7 produced by the hybridization of cRNA to vRNA of the A/FPV/Rostock strain. It corresponded instead to the heterologous hybrid cRNA/vRNA which migrated to this position after hybridization of cRNA from A/FPV/Rostock/34 to vRNA of the A/FPV/Weybridge strain. This may be due to a significant though incomplete homology of gene 7 (coding for M protein) in the different influenza viruses. The analysis of recombinants in 4~ polyacrylamide gels in the absence of urea confirmed that gene 7 was inherited by the recombinants from the sensitive A/FPV/Rostock/34 strain (not shown).
Thus the electrophoretic patterns clearly demonstrated that only the haemagglutinin-coding gene 4 of the Norakin-resistant recombinant R4 was derived from the Norakin-resistant parent strain whereas all the other gene segments were derived from the sensitive parent strain. Table 2 summarizes the results of the genome analyses of five recombinants by PAGE and urea-PAGE. All the resistant recombinants inherited the haemagglutinin gene from the resistant parent strain, and only one of the recombinants inherited an additional gene from the resistant parent, all other genes coming from the sensitive parent strain.
The results of the hybridization analyses were confirmed by haemagglutination-inhibition tests. All Norakin-resistant recombinants contained a haemagglutinin resembling that of the Norakin-resistant parent strain A/FPV/Weybridge r (data not shown).
Influence of Norakin on red blood celt lysis induced by FP V at acid pH
The studies described above suggest that FPV haemagglutinin might be a target for the antiviral activity of Norakin. As will be described elsewhere, Norakin inhibits the primary transcription of the FPV genome in CEF cultures (H. Heider et al., unpublished results) . This suggests that Norakin affects the early stages of FPV multiplication that involve the haemagglutinin. Preliminary experiments using purified virions labelled with 14C-amino acids revealed an effect of Norakin on the attachment of virions to the other membranes of sensitive cells (not shown). It was therefore assumed that Norakin may affect the fusion of the haemagglutinin with the cell membrane, which takes place at acid pH (Maeda et al., 1981; Lenard et al., 1982; Hosaka et al., 1983) , and we studied the effect of Norakin on red blood cell lysis induced by FPV at acid pH. These investigations will be described in detail elsewhere. The results in this report (Table 3) show that 200 lag/ml Norakin caused 60~ inhibition of the red blood cell lysis induced at pH 5.2 by purified FPV. At the same time this concentration of Norakin produced no effect on the red blood cell lysis induced at pH 5.2 by purified virions of the Norakin-resistant FPV variant. To confirm that the Norakin-induced inhibition of red * Ten ~lg of purified virions or 5 ~tg of haemagglutinin-containing autoliposomes were mixed with 200 lag Norakin, the volume was adjusted to 200 ~tl with MM buffer and 300 gtl of 8% red blood cells was added. The mixture was incubated for 10 min at 0 °C and 500 gd citrate buffer was added and incubated for a further 30 min at 37 °C.
t As~o.
:~ Percentage inhibition of lysis.
blood cell lysis was indeed due to its effect on the haemagglutinin, we prepared virion-derived autoliposomes containing lipid and F P V haemagglutinin. Electrophoresis of these preparations in polyacrylamide gels revealed only the presence of h a e m a g g l u t i n i n (Fig. 2a) . These preparations displayed pronounced haemagglutinating activity (5 × 105 H A U / m g protein), along with a sharp decrease in neuraminidase activity (not shown). It should be pointed out that preparations of autoliposomes containing both lipids and influenza virus haemagglutinin obtained by Hosaka et al. (1983) were also characterized by a sharply decreased n e u r a m i n i d a s e activity. Electron microscopy confirmed (see Fig. 2b ) that these preparations consisted of liposomes varying in structure and resembling circular membranous particles covered with spikes of haemagglutinin about 10 nm long.
As shown in Table 3 , Norakin caused 55 ~ inhibition of red blood cell lysis induced by these haemagglutinin-containing autoliposomes, while the lytic activity of similar preparations isolated from the Norakin-resistant FPV variant remained unchanged.
Influence of Norakin on the aggregation of FPV haemagglutinin at acid pH
The data in the literature suggest that, to induce fusion (red blood cell lysis) the influenza virus haemagglutinin must undergo certain conformational changes which take place only at acid pH (Skehel et al., 1982; Sato et al., 1983; Daniels et al., 1983) . The experiments with the haemagglutinin of influenza virus performed by Skehel et al. (1982) and Sato et al. (1983) demonstrated that these changes result in haemagglutinin aggregation which can be revealed by centrifugation in sucrose gradients and by electron microscopy. Sato et al. (1983) showed that intact virions of influenza virus also formed aggregates at acid pH. In the experiments of Kawasaki et al. (1983) and Hosaka et al. (1983) , red blood cell lysis could be induced by liposomes containing the influenza virus haemagglutinin; therefore, we studied the influence of Norakin on FPV haemagglutinin aggregation at acid pH using preparations of autoliposomes containing the FPV haemagglutinin whose characteristics are given above. Fig. 3 shows that FPV haemagglutinin-containing autoliposomes prepared from the Norakin-sensitive strain A/FPV/Weybridge when incubated in MM buffer at pH 7.0 and centrifuged peaked in fraction 12 from the bottom (equivalent to a sedimentation constant of about 400S). The same preparations incubated in citrate buffer at pH 5.2 were denser, with the peak in fraction 8 from the bottom (equivalent to a sedimentation constant of about 600S), testifying to the formation of aggregates. However, when incubation at pH 5.2 was performed in the presence of Norakin, the peak of haemagglutinin-containing autoliposomes corresponded to fraction 12, suggesting that Norakin disturbs the aggregation of haemagglutinin at acid pH. Similar incubation (at pH 5.2) in the presence of Norakin of haemagglutinin-containing autoliposomes derived from a Norakin-resistant FPV variant resulted in aggregation with the peak located at fraction 8 from the bottom.
Influence of Norakin on the sensitivity to trypsin at acid pH of the HA 1 subunit of haemagglutinin
The experiments of Skehel et al. (1982) and Sato et al. (1983) showed that the HA1 subunit of the haemagglutinin of influenza virus becomes sensitive to trypsin as a result of certain conformational changes occurring at acid pH. We studied the effect of Norakin on this process. As can be seen in Fig. 4 , trypsinization of haemagglutinin-containing autoliposomes (as in the experiments of Skehel et al., 1982) at pH 7.0 caused no change in HA1 or HA2, but at acid pH the HA1 subunit was markedly affected. As was also found by Skehel et al. (1982) and Sato et al. (1983) , this protein disintegrated to give a product with a mol. wt. of about 30000. No trypsininduced disintegration of HA1 at pH 5.2 was observed in the presence of Norakin.
DISCUSSION
Resistance to aminoadamantane (amantadine) is an established genetic marker of influenza A viruses (Appleyard, 1977) . Our results indicate that viral resistance to Norakin, another antiParkinsonism drug, is also determined genetically and can be transmitted by reassortment. Analysis of the genome of Norakin-resistant recombinants obtained upon crossing a Norakinresistant A/FPV/Weybridge variant with a Norakin-sensitive A/FPV/Rostock/34 strain indicates that the haemagglutinin-coding gene is responsible for Norakin resistance.
The results of studying the influence of Norakin on red blood cell lysis induced at acid pH by FPV virions or autoliposomes containing FPV haemagglutinin suggest that the haemagglutinin is the target for the antiviral activity of Norakin. The experiments on the aggregation of influenza virus haemagglutinin and the sensitivity of this protein to trypsin at various pH values as well as a number of other investigations carried out by various authors (Skehel et al., 1982; Sato et aL, 1983; Daniels et al., 1983) suggest that haemagglutinin can induce red blood cell lysis at acid pH only after conformational changes that take place at acid pH. The data obtained by studying the influence of Norakin on haemagglutinin aggregation, and the sensitivity of this protein to trypsin at acid pH, suggest that Norakin affects the ability of influenza virus haemagglutinin to undergo these changes, probably inhibiting its ability to induce red blood cell lysis.
All these data testify to the fact that the ability of Norakin to inhibit influenza virus reproduction is the result of disturbances at the fusion stage, because Norakin prevents the influenza virus haemagglutinin from changing its conformation at acid pH, the stage which is possibly indispensable for the fusion process. However, it is still possible that Norakin might exhibit additional effects at other stages of the multiplication of orthomyxoviruses.
